Heart failure is a progressive disease caused by impairment in the heart’s ability to pump blood to the various organs of the body. Patients with heart failure commonly experience shortness of breath, fatigue, difficulty exercising, and swelling of the legs. The heart becomes weak or stiff and enlarges over time making it harder to pump the blood needed for the body to function properly.
Heart failure is a major cause of illness in the United States and other Western societies and typically results in reduced life expectancy.
6 million patients in U.S. suffer from heart failure
670,000 new cases of heart failure are diagnosed each year
The chance of developing heart failure increases sharply with age
The number of patients with heart failure in the U.S. is expected to double in the next 20 years
It is estimated that the direct and indirect U.S. costs for heart failure were $39.2 billion in 2009
9.3% of men and 4.8% of women in the U.S. within the age group 60-79 have heart failure
Heart failure is more common in blacks than whites (4.2% of blacks vs 2.4% of whites)
(Heart Disease and Stroke Statistics 2009 Update. A Report From the AHA Statistics Committee and Stroke Statistics Subcommittee. Lloyd-Jones D, et al. Circulation 2009;119:e1-161.)
Causes of Heart Failure
Heart failure can be caused by a large number of different underlying diseases. The most common causes of heart failure are:
1. Previous heart attack(s) or Ischemic heart disease 2. Valvular heart disease (marked obstruction or leaking of a heart valve) 3. Persistent high blood pressure or Hypertensive heart disease 4. Viral or Idiopathic (unknown) 5. Alcoholic abuse (long-term heavy alcohol consumption) 6. Genetic diseases
Diagnosing Heart Failure
The diagnosis of heart failure is made by a physician based on a combination of multiple variables including symptoms, physical examination, laboratory and imaging tests. Findings that support a diagnosis of heart failure include:
Symptoms A. Exercise intolerance, fatigue, cool hands and feet - known as “Forward failure” B. Shortness of breath, swelling of abdomen and legs/feet - known as “Backward failure”
Physical examination Swollen veins in neck, crackling in lungs, swelling of legs/feet, and abnormal heart sounds
Laboratory Tests A. Elevated B-type natriuretic peptide (BNP) B. Electrocardiogram: evidence of heart attack
Electrocardiogram - Normal ST SegmentsElectrocardiogram – ST Segment Elevation
Imaging A. Chest X-ray: enlarged heart and fluid in lungs
B. Echocardiogram (ultrasound of heart): decreased pumping function, abnormal heart chamber size or wall thickness, valvular disease
Heart Failure Echo prior to CRT device
Heart Failure Echo after placement of CRT device
LV Function is markedly impaired
LV size is smaller and function is improved
C. CT angiogram
D. MRI
MRI Normal
MRI Heart Failure
Left Ventricle function and size is normal
Left Ventricle is enlarged and function is severely impaired
E. Heart catheterization and coronary angiogram
Angiogram with narrowing of coronary artery
Angiogram following placement of stent to open obstruction
Your physician will determine which test(s) you may need.
Classifications of Heart Failure
The severity of Heart Failure depends on how well your heart is still able to pump blood to your body. The most common measure of heart failure severity is NYHA (New York Heart Association) Class guideline. Patients are classified as follows based on their symptoms and functional limitations.
Class I (Mild): You have no limits to your daily activities. You are able to do all of your normal daily activities without becoming tired, short of breath or having heart palpitations.
Class II (Mild): You have some limits to your daily activities. You are comfortable at rest, but normal activities may cause you to be tired, short of breath or have heart palpitations.
Class III (Moderate): Your daily activities are greatly limited. You are comfortable at rest, but are unable to do daily activities without becoming tired, short of breath or having heart palpitations.
Class IV (Severe): You are unable to do any physical activity without discomfort. You become tired, short of breath and possibly have heart palpitations even when you are at rest. Any physical activity makes your discomfort worse.
Treatment of Heart Failure
Lifestyle
Patients with heart failure are initially treated with education about heart failure and about the importance of lifestyle changes. Changing behavior can have a dramatic impact on a patient’s symptoms of heart failure and on the progression of their disease. The following lifestyle changes help delay or prevent disease progression or help to reduce the workload placed on the heart.
1. Discontinuing smoking and alcohol use 2. Regular aerobic exercise 3. Weight loss 4. Low sodium diet
Drug Therapy
Most patients with heart failure will need drug therapy, often requiring multiple drugs. Drug types commonly used for heart failure and associated conditions are listed in the following table.
drug type
drug example
mechanism
benefit
ACE-Inhibitor
Lisinopril
Lower BP
Improve heart structure and function
Diuretic
Furosemide
Increase salt and water excretion
Relieve congestion (swelling, shortness of breath)
Beta-blocker
Carvedilol
Lower HR and BP
Improve heart structure and function
Aldosterone antagonist
Spironolactone
Block aldosterone effects
Improve heart structure and function
Digitalis
Digoxin
Increase heart contractility
Improve heart function
Antiarrhythmic
Amiodarone
Reduce abnormal heart rhythms
Reduce tachycardia or sudden death
Anticoagulant
Coumadin
Thin blood
Reduce risk of stroke
Antiplatelet
Aspirin
Thin blood
Reduce risk of vascular events
Statin
Simvastatin
Lower cholesterol
Reduce risk of MI, stroke
Inotropic agent
Dobutamine
Increase heart contractility
Improve heart function
Invasive Procedures and Devices
Coronary revascularization This therapy is for patients with significant coronary artery disease. These patients may or may not have had a previous heart attack. Treatment can be via heart catheterization with balloon angioplasty or stent placement. Alternatively, coronary artery bypass surgery can be performed.
Implantable cardioverter defibrillator (ICD) placement This therapy typically involves implanting a generator in the upper chest with one or more leads (wires) running through veins into the heart. The heart rhythm can be monitored, and the heart can be shocked if there is a dangerous or life-threatening abnormal heart rhythm detected. Dangerous heart rhythm abnormalities include bradycardia (slow heart rate) or tachycardia (fast heart rate).
Biventricular pacemaker placement (also called cardiac resynchronization therapy: CRT) This therapy involves implanting a generator in the upper chest and three leads into the heart. The leads are placed putting one in the right atrium, one in the right ventricle and one in the coronary sinus overlying the left ventricle. This therapy is often combined with a defibrillator in a single device. Standard indications for this therapy include:
Left ventricular ejection fraction < 35%
Wide (> 120 ms) QRS complex on ECG
Advanced symptoms of heart failure on good medical therapy
Left ventricular assist devices (LVAD)
This therapy has recently been approved for patients with very advanced heart failure. A number of different devices are being studied and used in patients. These devices act to support the failing heart by assisting in improving blood output from the left ventricle to the body. An example of one type of LVAD is shown.
From Medscape® (www.medscape.com)
Heart transplantation Heart transplantation is a surgery that involves removing a seriously damaged heart from a patient with heart failure and replacing it with a healthy heart from an individual who has recently died. Heart transplantation is a therapy reserved for very sick heart failure patients who have severe symptoms of heart failure despite aggressive drug and/or device therapy. Survival following heart transplantation is about 85% at 1 year and 70% at 5 years. Approximately 4,000 people are on waiting lists for heart transplantation but only about 2,000 heart transplants are performed each year due to the limited number of donor hearts.
Heart Failure Care Providers
A number of different models of health care are used to manage patients with heart failure. The care of heart failure patients, especially those with advanced disease, often is best provided by a team of health care specialists. Each individual plays an important role in caring for patients with this disease. Some of the key individuals and their roles are described below.
Primary Care Physicians: These physicians often manage the overall care of the heart failure patient and work with other specialists in collaboration to care for the patient.
General Cardiologists: Many heart failure patients are seen and managed by General Cardiologists.
Heart Failure Cardiologists: Some Cardiologists specialize in the care of heart failure patients. These physicians often see patients with more complex or advanced disease.
Heart Failure Nurse Clinicians or Nurse Practitioners: These individuals are specially trained in heart failure and perform services such as patient education, drug monitoring and titration and disease management. They usually work in close collaboration with a Cardiologist.
Electrophysiologists: These Cardiology physicians specialize in electrical abnormalities of the heart. They treat abnormal heart rhythms, and implant pacemakers and defibrillators (devices which can electrically shock the heart out of dangerous rhythms).
Cardiac Surgeons: These specialists perform surgeries on patients with heart failure such as coronary artery bypass surgery, valve surgery and heart transplantation, among other things.
Role of C-Pulse®
There are many treatment options available for patients with heart failure. The C-Pulse device is an investigational therapeutic option for patients with moderate to severe heart failure that is used in combination with many of the previously mentioned heart failure therapies. Lifestyle changes, medications, biventricular pacemakers and/or defibrillators may be used together with the C-Pulse device to improve symptoms of heart failure in patients with advanced disease. C-Pulse therapy is an option as part of an investigational research study for treatment of patients with NYHA Class III and ambulatory Class IV heart failure. In order to potentially qualify for participation in a trial of this therapy, patients must have significantly reduced heart function, reduced exercise capacity and no previous open-heart bypass surgery. In these patients the disease is not typically advanced enough to warrant a left ventricular assist device or heart transplantation. Contact your physician if you have additional questions.
Content for this section provided by: Alan Bank, M.D., Heart Failure Cardiologist St. Paul Heart Clinic, St Paul, MN
Stages of Heart Failure
No limitation of physical activity. Ordinary physical activity does not cause undue fatigue, heart palpitation, or dyspnea (shortness of breath).
Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity may result in fatigue, heart palpitation, or dyspnea.
Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity casues fatigue, heart palpitation, or dyspnea.
Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If physical activity is undertaken, discomfort is increased.
C-Pulse is a registered trademark of Sunshine Heart, Inc. and is registered in the United States Patent and Trademark Office.
The C-Pulse Heart Assist is undergoing clinical evaluation and is not available for commercial sale. C-Pulse is an Investigational device. The device is limited by Federal (or United States) Law to Investigational use only. It is not available for sale in the United States.